Autosomal dominant Parkinson's disease caused by SNCA duplications

Parkinsonism and Related Disorders

Volumn 22, Issue , 2016, Pages S1-S6

  Konno, Takuya ^a   Ross, Owen A ^b   Puschmann, Andreas ^c   Dickson, Dennis W ^a   Wszolek, Zbigniew K ^a  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c LUND UNIVERSITY   (Sweden)

Author keywords

Alpha synuclein; Duplication; Parkinson's disease; Pathology; SNCA

Indexed keywords

TAR DNA BINDING PROTEIN; ALPHA SYNUCLEIN; SNCA PROTEIN, HUMAN;

ARTICLE; AUTOPSY; AUTOSOMAL DOMINANT DISORDER; CELL LOSS; CLINICAL FEATURE; COGNITIVE DEFECT; DEPRESSION; DIFFUSE LEWY BODY DISEASE; DYSAUTONOMIA; GENE; GENE DUPLICATION; GENETIC ANALYSIS; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA2 REGION; HIPPOCAMPAL CA3 REGION; HUMAN; LOCUS CERULEUS; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NEURONAL LOSS; NEUROPATHOLOGY; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; REM SLEEP DEPRIVATION; SHY DRAGER SYNDROME; SNCA GENE; SUBSTANTIA NIGRA; SYMPTOM; VISUAL HALLUCINATION; ADULT; CASE REPORT; GENETICS; MALE; PARKINSONIAN DISORDERS; PEDIGREE;

ADULT; ALPHA-SYNUCLEIN; GENE DUPLICATION; HUMANS; MALE; MUTATION, MISSENSE; PARKINSONIAN DISORDERS; PEDIGREE;

EID: 84947866080     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2015.09.007     Document Type: Article

References (29)

1. Spatola M., Wider C. Genetics of Parkinson's disease: the yield. Park. Relat. Disord. 2014, 20(Suppl. 1):S35-S38.
2. Puschmann A. Monogenic Parkinson's disease and parkinsonism: clinical phenotypes and frequencies of known mutations. Park. Relat. Disord. 2013, 19:407-415.
3. Sharma M., Ioannidis J.P., Aasly J.O., Annesi G., Brice A., Bertram L., Bozi M., Barcikowska M., Crosiers D., Clarke C.E., Facheris M.F., Farrer M., Garraux G., Gispert S., Auburger G., Vilariño-Güell C., Hadjigeorgiou G.M., Hicks A.A., Hattori N., Jeon B.S., Jamrozik Z., Krygowska-Wajs A., Lesage S., Lill C.M., Lin J.J., Lynch T., Lichtner P., Lang A.E., Libioulle C., Murata M., Mok V., Jasinska-Myga B., Mellick G.D., Morrison K.E., Meitnger T., Zimprich A., Opala G., Pramstaller P.P., Pichler I., Park S.S., Quattrone A., Rogaeva E., Ross O.A., Stefanis L., Stockton J.D., Satake W., Silburn P.A., Strom T.M., Theuns J., Tan E.K., Toda T., Tomiyama H., Uitti R.J., Van Broeckhoven C., Wirdefeldt K., Wszolek Z., Xiromerisiou G., Yomono H.S., Yueh K.C., Zhao Y., Gasser T., Maraganore D., Krüger R. A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants. J. Med. Genet. 2012, 49:721-726. GEOPD consortium.
4. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G., Golbe L.I., Nussbaum R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997, 276:2045-2047.
5. Fujioka S., Ogaki K., Tacik P.M., Uitti R.J., Ross O.A., Wszolek Z.K. Update on novel familial forms of Parkinson's disease and multiple system atrophy. Park. Relat. Disord. 2014, 20(Suppl. 1):S29-S34.
6. Antonini A., Pilleri M., Padoan A., Landi A., Ferla S., Biundo R., D'Avella D. Successful subthalamic stimulation in genetic Parkinson's disease caused by duplication of the α-synuclein gene. J. Neurol. 2012, 259:165-167.
7. Shimo Y., Natori S., Oyama G., Nakajima M., Ishii H., Arai H., Hattori N. Subthalamic deep brain stimulation for a Parkinson's disease patient with duplication of SNCA. Neuromodulation 2014, 17:102-103.
8. Ahn T.B., Kim S.Y., Kim J.Y., Park S.S., Lee D.S., Min H.J., Kim Y.K., Kim S.E., Kim J.M., Kim H.J., Cho J., Jeon B.S. Alpha-synuclein gene duplication is present in sporadic Parkinson disease. Neurology 2008, 70:43-49.
9. Ikeuchi T., Kakita A., Shiga A., Kasuga K., Kaneko H., Tan C.F., Idezuka J., Wakabayashi K., Onodera O., Iwatsubo T., Nishizawa M., Takahashi H., Ishikawa A. Patients homozygous and heterozygous for SNCA duplication in a family with parkinsonism and dementia. Arch. Neurol. 2008, 65:514-519.
10. Kojovic M., Sheerin U.M., Rubio-Agusti I., Saha A., Bras J., Gibbons V., Palmer R., Houlden H., Hardy J., Wood N.W., Bhatia K.P. Young-onset parkinsonism due to homozygous duplication of α-synuclein in a consanguineous family. Mov. Disord. 2012, 27:1827-1829.
11. Ross O.A., Braithwaite A.T., Skipper L.M., Kachergus J., Hulihan M.M., Middleton F.A., Nishioka K., Fuchs J., Gasser T., Maraganore D.M., Adler C.H., Larvor L., Chartier-Harlin M.C., Nilsson C., Langston J.W., Gwinn K., Hattori N., Farrer M.J. Genomic investigation of alpha-synuclein multiplication and parkinsonism. Ann. Neurol. 2008, 63:743-750.
12. Ibáñez P., Lesage S., Janin S., Lohmann E., Durif F., Destée A., Bonnet A.M., Brefel-Courbon C., Heath S., Zelenika D., Agid Y., Dürr A., Brice A. French Parkinson's Disease Genetics Study Group. Alpha-synuclein gene rearrangements in dominantly inherited parkinsonism: frequency, phenotype, and mechanisms. Arch. Neurol. 2009, 66:102-108.
13. Garraux G., Caberg J.H., Vanbellinghen J.F., Jamar M., Bours V., Moonen G., Dive D. Partial trisomy 4q associated with young-onset dopa-responsive parkinsonism. Arch. Neurol. 2012, 69:398-400.
14. Brueggemann N., Odin P., Gruenewald A., Tadic V., Hagenah J., Seidel G., Lohmann K., Klein C., Djarmati A. Re: alpha-synuclein gene duplication is present in sporadic Parkinson disease. Neurology 2008, 71:1294.
15. Fuchs J., Nilsson C., Kachergus J., Munz M., Larsson E.M., Schüle B., Langston J.W., Middleton F.A., Ross O.A., Hulihan M., Gasser T., Farrer M.J. Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication. Neurology 2007, 68:916-922.
16. Ishikawa A., Takahashi H., Tanaka H., Hayashi T., Tsuji S. Clinical features of familial diffuse Lewy body disease. Eur. Neurol. 1997, 38(Suppl. 1):34-38.
17. Wakabayashi K., Hayashi S., Ishikawa A., Hayashi T., Okuizumi K., Tanaka H., Tsuji S., Takahashi H. Autosomal dominant diffuse Lewy body disease. Acta Neuropathol. 1998, 96:207-210.
18. Nishioka K., Hayashi S., Farrer M.J., Singleton A.B., Yoshino H., Imai H., Kitami T., Sato K., Kuroda R., Tomiyama H., Mizoguchi K., Murata M., Toda T., Imoto I., Inazawa J., Mizuno Y., Hattori N. Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson's disease. Ann. Neurol. 2006, 59:298-309.
19. Obi T., Nishioka K., Ross O.A., Terada T., Yamazaki K., Sugiura A., Takanashi M., Mizoguchi K., Mori H., Mizuno Y., Hattori N. Clinicopathologic study of a SNCA gene duplication patient with Parkinson disease and dementia. Neurology 2008, 70:238-241.
20. Nishioka K., Ross O.A., Ishii K., Kachergus J.M., Ishiwata K., Kitagawa M., Kono S., Obi T., Mizoguchi K., Inoue Y., Imai H., Takanashi M., Mizuno Y., Farrer M.J., Hattori N. Expanding the clinical phenotype of SNCA duplication carriers. Mov. Disord. 2009, 24:1811-1819.
21. Kara E., Kiely A.P., Proukakis C., Giffin N., Love S., Hehir J., Rantell K., Pandraud A., Hernandez D.G., Nacheva E., Pittman A.M., Nalls M.A., Singleton A.B., Revesz T., Bhatia K.P., Quinn N., Hardy J., Holton J.L., Houlden H.A. 6.4 Mb duplication of the α-synuclein locus causing frontotemporal dementia and Parkinsonism: phenotype-genotype correlations. JAMA Neurol. 2014, 71:1162-1171.
22. Poulopoulos M., Levy O.A., Alcalay R.N. The neuropathology of genetic Parkinson's disease. Mov. Disord. 2012, 27:831-842.
23. Dickson D.W., Ruan D., Crystal H., Mark M.H., Davies P., Kress Y., Yen S.H. Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD. Neurology 1991, 41:1402-1409.
24. McKeith I.G., Dickson D.W., Lowe J., Emre M., O'Brien J.T., Feldman H., Cummings J., Duda J.E., Lippa C., Perry E.K., Aarsland D., Arai H., Ballard C.G., Boeve B., Burn D.J., Costa D., Del Ser T., Dubois B., Galasko D., Gauthier S., Goetz C.G., Gomez-Tortosa E., Halliday G., Hansen L.A., Hardy J., Iwatsubo T., Kalaria R.N., Kaufer D., Kenny R.A., Korczyn A., Kosaka K., Lee V.M., Lees A., Litvan I., Londos E., Lopez O.L., Minoshima S., Mizuno Y., Molina J.A., Mukaetova-Ladinska E.B., Pasquier F., Perry R.H., Schulz J.B., Trojanowski J.Q., Yamada M. Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium. Neurology 2005, 65:1863-1872. Consortium on DLB.
25. Farrer M., Kachergus J., Forno L., Lincoln S., Wang D.S., Hulihan M., Maraganore D., Gwinn-Hardy K., Wszolek Z., Dickson D., Langston J.W. Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications. Ann. Neurol. 2004, 55:174-179.
26. Markopoulou K., Dickson D.W., McComb R.D., Wszolek Z.K., Katechalidou L., Avery L., Stansbury M.S., Chase B.A. Clinical, neuropathological and genotypic variability in SNCA A53T familial Parkinson's disease. Variability in familial Parkinson's disease. Acta Neuropathol. 2008, 116:25-35.
27. Aoki N., Murray M.E., Ogaki K., Fujioka S., Rutherford N.J., Rademakers R., Ross O.A., Dickson D.W. Hippocampal sclerosis in Lewy body disease is a TDP-43 proteinopathy similar to FTLD-TDP Type A. Acta Neuropathol. 2015, 129:53-64.
28. Fujishiro H., Imamura A.Y., Lin W.L., Uchikado H., Mark M.H., Golbe L.I., Markopoulou K., Wszolek Z.K., Dickson D.W. Diversity of pathological features other than Lewy bodies in familial Parkinson's disease due to SNCA mutations. Am. J. Neurodegener. Dis. 2013, 2:266-275.
29. Orimo S., Uchihara T., Nakamura A., Mori F., Ikeuchi T., Onodera O., Nishizawa M., Ishikawa A., Kakita A., Wakabayashi K., Takahashi H. Cardiac sympathetic denervation in Parkinson's disease linked to SNCA duplication. Acta Neuropathol. 2008, 116:575-577.